Drug-Interaction Assessment of GSK3772701 in Healthy Male and Female Participants Aged 18 to 55 Years

NCT07670377 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria, Falciparum

Interventions

DRUG: Midazolam (MDZ)
DRUG: GSK3772701

Sponsor

GlaxoSmithKline